+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Hyoscine Market by Type, Mode of Administration - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5674584
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Hyoscine Market grew from USD 439.16 million in 2023 to USD 460.41 million in 2024. It is expected to continue growing at a CAGR of 4.66%, reaching USD 604.28 million by 2030.

Hyoscine, also known as scopolamine, is a tropane alkaloid derived from plants of the nightshade family. It is primarily utilized in the pharmaceutical industry for its anticholinergic properties, effectively treating motion sickness, nausea, muscle spasms, and postoperative nausea. The substance operates by blocking certain nerve signals within the central nervous system, helping mitigate symptoms related to other conditions such as irritable bowel syndrome and even certain psychiatric disorders. Market necessity for hyoscine is driven by a growing prevalence of travel-related motion sickness, increased surgical procedures necessitating anti-nausea treatments, and expanding research on neurological disorders. A key growth influencer is the rising demand for advanced therapeutic applications across diverse medical fields, underpinned by an aging global population. Furthermore, developing healthcare systems in emerging markets are accelerating demand, providing substantial opportunities. However, challenges such as regulatory limitations, potential side effects, and the availability of alternative treatments may restrain growth. Intellectual property considerations and stringent clinical testing requirements also pose barriers. From an innovation perspective, further research into less invasive delivery methods, such as transdermal patches and novel oral formulations, can enhance user compliance and expand usage scope. There is also potential in exploring hyoscine’s efficacy in new therapeutic areas, such as its use as an adjuvant in anesthesia or in the treatment of migraines. Companies should focus on strategic partnerships to facilitate R&D and access to cutting-edge delivery technologies. While the hyoscine market exhibits moderate competitiveness, entering niches within developing economies and forging collaborations with local healthcare providers could yield significant advantages. In conclusion, fostering innovation in product formulation and exploring untapped markets offer the best pathways to business growth, but stakeholders must navigate regulatory landscapes and address safety concerns to fully capitalize on this promising market.

Understanding Market Dynamics in the Hyoscine Market

The Hyoscine Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing awareness about the use of hyoscine as an apt medicine against motion sickness
    • Growing number of travelers and international tourism
    • Availability of hyoscine as over-the-counter medicine
  • Market Restraints
    • High cost and stringent regulatory protocols
  • Market Opportunities
    • Increase in usage of transdermal hyoscine patches in surgeries & post-operative recovery
    • Improvements in production process of hyoscine
  • Market Challenges
    • Side effects associated with hyoscine

Exploring Porter’s Five Forces for the Hyoscine Market

Porter’s Five Forces framework further strengthens the insights of the Hyoscine Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Hyoscine Market

External macro-environmental factors deeply influence the performance of the Hyoscine Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Hyoscine Market

The Hyoscine Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Hyoscine Market

The Hyoscine Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Hyoscine Market

The Hyoscine Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hyoscine Market, highlighting leading vendors and their innovative profiles. These include Alchem International Pvt. Ltd., Alkaloids Corporation, Baxter International, Inc., C-Squared Pharma S.à R.L., Caleb Pharmaceuticals, Inc, GlaxoSmithKline PLC, Linnea SA, Merck KGaA, Morningside Healthcare Limited by Aspire Pharma Limited, Myungmoon Pharm Co., Ltd., Perrigo Company PLC, Pfizer Inc., Sanofi S.A., Teva Pharmaceuticals Industries Ltd., and Wockhardt UK Limited.

Market Segmentation & Coverage

This research report categorizes the Hyoscine Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Hyoscine Butylbromide
    • Hyoscine Hydrobromide
  • Mode of Administration
    • Injections
    • Oral
    • Patches
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing awareness about the use of hyoscine as an apt medicine against motion sickness
5.1.1.2. Growing number of travelers and international tourism
5.1.1.3. Availability of hyoscine as over-the-counter medicine
5.1.2. Restraints
5.1.2.1. High cost and stringent regulatory protocols
5.1.3. Opportunities
5.1.3.1. Increase in usage of transdermal hyoscine patches in surgeries & post-operative recovery
5.1.3.2. Improvements in production process of hyoscine
5.1.4. Challenges
5.1.4.1. Side effects associated with hyoscine
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Hyoscine Market, by Type
6.1. Introduction
6.2. Hyoscine Butylbromide
6.3. Hyoscine Hydrobromide
7. Hyoscine Market, by Mode of Administration
7.1. Introduction
7.2. Injections
7.3. Oral
7.4. Patches
8. Americas Hyoscine Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Hyoscine Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Hyoscine Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. HYOSCINE MARKET RESEARCH PROCESS
FIGURE 2. HYOSCINE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL HYOSCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL HYOSCINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL HYOSCINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL HYOSCINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 11. AMERICAS HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES HYOSCINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 13. UNITED STATES HYOSCINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. HYOSCINE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 19. HYOSCINE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. HYOSCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL HYOSCINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HYOSCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL HYOSCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. HYOSCINE MARKET DYNAMICS
TABLE 7. GLOBAL HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL HYOSCINE MARKET SIZE, BY HYOSCINE BUTYLBROMIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL HYOSCINE MARKET SIZE, BY HYOSCINE HYDROBROMIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL HYOSCINE MARKET SIZE, BY INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL HYOSCINE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL HYOSCINE MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS HYOSCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 17. ARGENTINA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 20. BRAZIL HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 21. CANADA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 22. CANADA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 23. MEXICO HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 24. MEXICO HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES HYOSCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 30. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. AUSTRALIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. AUSTRALIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 33. CHINA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. CHINA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 35. INDIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. INDIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 37. INDONESIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. INDONESIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 39. JAPAN HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. JAPAN HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 41. MALAYSIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. MALAYSIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 43. PHILIPPINES HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. PHILIPPINES HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 45. SINGAPORE HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. SINGAPORE HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 47. SOUTH KOREA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. SOUTH KOREA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 49. TAIWAN HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. TAIWAN HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 51. THAILAND HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. THAILAND HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 53. VIETNAM HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. VIETNAM HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. DENMARK HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. DENMARK HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 60. EGYPT HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. EGYPT HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 62. FINLAND HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. FINLAND HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. FRANCE HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. FRANCE HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 66. GERMANY HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. GERMANY HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 68. ISRAEL HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. ISRAEL HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 70. ITALY HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. ITALY HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. NETHERLANDS HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. NETHERLANDS HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 74. NIGERIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. NIGERIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 76. NORWAY HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. NORWAY HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 78. POLAND HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. POLAND HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 80. QATAR HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. QATAR HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. SAUDI ARABIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. SOUTH AFRICA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 88. SPAIN HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. SPAIN HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 90. SWEDEN HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. SWEDEN HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 92. SWITZERLAND HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. SWITZERLAND HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 94. TURKEY HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. TURKEY HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 100. HYOSCINE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 101. HYOSCINE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Hyoscine Market, which are profiled in this report, include:
  • Alchem International Pvt. Ltd.
  • Alkaloids Corporation
  • Baxter International, Inc.
  • C-Squared Pharma S.à R.L.
  • Caleb Pharmaceuticals, Inc
  • GlaxoSmithKline PLC
  • Linnea SA
  • Merck KGaA
  • Morningside Healthcare Limited by Aspire Pharma Limited
  • Myungmoon Pharm Co., Ltd.
  • Perrigo Company PLC
  • Pfizer Inc.
  • Sanofi S.A.
  • Teva Pharmaceuticals Industries Ltd.
  • Wockhardt UK Limited

Methodology

Loading
LOADING...

Table Information